Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 03, 2015 9:26 AM ET

Biotechnology

Company Overview of OncoMed Pharmaceuticals, Inc.

Key Executives for OncoMed Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Paul J. Hastings 239 RelationshipsChairman, Chief Executive Officer and President54
Sunil Patel 14 RelationshipsChief Financial Officer and Senior Vice President of Corporate Development & Finance42
Jakob Dupont M.D.No RelationshipsChief Medical Officer and Senior Vice President49
Austin Gurney Ph.D.No RelationshipsSenior Vice President of Molecular and Cellular Biology50
Alicia J. Hager J.D., Ph.D.No RelationshipsVice President and General Counsel44
View More Key Executives

OncoMed Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Paul J. Hastings 239 RelationshipsOncoMed Pharmaceuticals, Inc.54
Jonathan D. Root M.D. 88 RelationshipsU.S. Venture Partners54
Jack W. Lasersohn J.D. 29 RelationshipsThe Vertical Group61
Michael S. Wyzga 56 RelationshipsRadius Health, Inc.59
Laurence A. Lasky Ph.D. 65 RelationshipsOncoMed Pharmaceuticals, Inc.63
View All Board Members

OncoMed Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Michael S. Wyzga56 Relationships3 Executives
Compensation Committee M.D.Jonathan D. Root88 Relationships3 Executives
Nominating Committee J.D.Jack W. Lasersohn29 Relationships3 Executives
Corporate Governance Committee J.D.Jack W. Lasersohn29 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$469.5K
469.5K
394.0K
Bonus
Not meaningful
Total Short Term Compensation$9.3M
Not meaningful
Total Value of Options$469.5K
469.5K
33.2M
Compensation as of Fiscal Year 2014
OncoMed Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Energizer Holdings Inc. Announce Composition of New Boards of Directors
April 27, 2015 9:00 PM ET
Anders Nyrén to Leave His Assignment as Member of SCA Board of Directors as of April 30, 2015
April 27, 2015 5:58 AM ET
The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET
Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET
Oil-Dri Corp. of America Announces Management Changes
April 17, 2015 8:15 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OncoMed Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.